Stock Analysis on Net

Micron Technology Inc. (NASDAQ:MU)

Cash Flow Statement 
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Micron Technology Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: May 29, 2025 Feb 27, 2025 Nov 28, 2024 Aug 29, 2024 May 30, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 Jun 1, 2023 Mar 2, 2023 Dec 1, 2022 Sep 1, 2022 Jun 2, 2022 Mar 3, 2022 Dec 2, 2021 Sep 2, 2021 Jun 3, 2021 Mar 4, 2021 Dec 3, 2020 Sep 3, 2020 May 28, 2020 Feb 27, 2020 Nov 28, 2019 Aug 29, 2019 May 30, 2019 Feb 28, 2019 Nov 29, 2018
Net income (loss) 1,885 1,583 1,870 887 332 793 (1,234) (1,430) (1,896) (2,312) (195) 1,492 2,626 2,263 2,306 2,720 1,735 603 803 990 805 407 508 586 851 1,625 3,296
Depreciation expense and amortization of intangible assets 2,094 2,079 2,030 1,986 1,955 1,924 1,915 1,937 1,956 1,942 1,921 1,882 1,821 1,742 1,671 1,621 1,557 1,549 1,487 1,567 1,422 1,365 1,296 1,416 1,360 1,313 1,335
Stock-based compensation 253 249 220 213 219 213 188 148 145 157 146 136 131 129 118 93 96 97 92 89 82 85 72 67 58 57 61
Provision to write-down inventories to net realizable value 401 1,430
Goodwill impairment 101
Receivables (461) 1,155 (817) (1,019) (803) (1,258) (501) 35 (182) 1,068 1,842 1,096 (862) (111) 67 (1,106) (873) 282 251 (262) (565) 312 (208) 58 1,171 1,013 189
Inventories 280 (302) 170 (363) (68) (168) 111 (149) (510) (1,199) (1,697) (1,033) (246) (556) (344) 52 185 543 86 (203) (196) (265) 175 (213) (515) (514) (286)
Other current assets (2) (204)
Accounts payable and accrued expenses 752 (473) (241) 1,069 273 302 271 (189) 31 (514) (630) 362 275 149 (42) 519 468 (24) (753) 25 443 79 178 529 (377) (280) (46)
Other current liabilities (360) (160) (161) 220 63 127 579 (140) (39) (208) (430)
Change in operating assets and liabilities 209 16 (1,049) (93) (535) (997) 460 (443) (700) (853) (915) 425 (833) (518) (319) (535) (220) 801 (416) (440) (318) 126 145 374 279 219 (143)
Other 168 15 173 412 511 (714) 72 (64) 118 (21) (14) (158) 93 12 162 (15) 392 7 1 65 32 18 (10) (210) 163 221 261
Adjustments to reconcile net income (loss) to net cash provided by operating activities 2,724 2,359 1,374 2,518 2,150 426 2,635 1,679 1,920 2,655 1,138 2,285 1,212 1,365 1,632 1,164 1,825 2,454 1,164 1,281 1,218 1,594 1,503 1,647 1,860 1,810 1,514
Net cash provided by operating activities 4,609 3,942 3,244 3,405 2,482 1,219 1,401 249 24 343 943 3,777 3,838 3,628 3,938 3,884 3,560 3,057 1,967 2,271 2,023 2,001 2,011 2,233 2,711 3,435 4,810
Expenditures for property, plant, and equipment (2,938) (4,055) (3,206) (3,120) (2,086) (1,384) (1,796) (1,461) (1,561) (2,205) (2,449) (3,613) (2,578) (2,611) (3,265) (2,015) (2,259) (3,018) (2,738) (2,280) (1,944) (2,056) (1,943) (2,028) (2,403) (2,649) (2,700)
Purchases of available-for-sale securities (387) (439) (377) (889) (645) (266) (199) (227) (203) (203) (90) (411) (437) (394) (528) (1,244) (570) (347) (1,002) (1,064) (227) (159) (407) (404) (1,248) (519) (2,047)
Proceeds from government incentives 266 963 65 48 33 149 85 462 184 62 2 11 38 11 55 160 159 136 40 122 35 83 22 80 213 219 236
Proceeds from maturities and sales of available-for-sale securities 375 446 428 361 707 352 374 399 419 411 362 393 419 366 437 609 573 663 261 479 211 431 1,151 1,148 1,346 414 137
Proceeds from sale of Lehi, Utah fab (5) 893
Other 95 (67) (58) 2 (11) (2) (22) (3) (19) 20 (91) (204) (22) (63) (77) (44) 16 10 21 5 (27) (9) (12) 104 26 43 (53)
Net cash used for investing activities (2,589) (3,152) (3,148) (3,598) (2,002) (1,151) (1,558) (830) (1,180) (1,915) (2,266) (3,824) (2,585) (2,691) (2,485) (2,534) (2,081) (2,556) (3,418) (2,738) (1,952) (1,710) (1,189) (1,100) (2,066) (2,492) (4,427)
Proceeds from issuance of debt 1,748 2,682 999 1,495 1,872 3,349 2,000 1,188 3,750 1,250 1,750 1,800
Repayments of debt (978) (2,542) (84) (81) (715) (1,048) (53) (55) (653) (33) (20) (24) (27) (32) (1,949) (176) (1,241) (19) (84) (80) (2,610) (261) (1,415) (964) (1,671) (128) (577)
Payments of dividends to shareholders (131) (130) (131) (129) (128) (127) (129) (126) (126) (126) (126) (126) (111) (112) (112)
Payments on equipment purchase contracts (22) (45) (26) (56) (26) (36) (29) (47) (9) (27) (27) (78) (156) (16) (26) (97) (14) (20) (18) (11) (21) (17) (17) (20)
Repurchases of common stock, repurchase program (300) (425) (784) (981) (408) (259) (1,050) (150) (48) (44) (70) (89) (2) (159) (732) (1,836)
Acquisition of noncontrolling interest in IMFT (744)
Other (99) 86 (207) 58 (22) 96 (114) 95 (19) 118 (99) 103 (15) 113 (115) 38 (9) 50 (33) (40) (4) 134 17 129 29 (2)
Net cash provided by (used for) financing activities 540 96 (422) (474) (910) (106) (352) (112) 661 1,802 2,632 (840) (1,161) (466) (513) (1,344) (228) 5 (214) (182) 1,072 (215) (992) 892 (1,847) 952 (2,435)
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash 46 (20) (29) 55 (7) (7) (1) (21) (22) 15 (6) (35) (55) (10) (6) (3) 1 16 27 19 6 (14) 20 7 9 (10)
Net increase (decrease) in cash, cash equivalents, and restricted cash 2,606 866 (355) (612) (437) (45) (510) (714) (517) 245 1,303 (922) 37 461 934 3 1,252 522 (1,638) (630) 1,149 76 (184) 2,045 (1,195) 1,904 (2,062)

Based on: 10-Q (reporting date: 2025-05-29), 10-Q (reporting date: 2025-02-27), 10-Q (reporting date: 2024-11-28), 10-K (reporting date: 2024-08-29), 10-Q (reporting date: 2024-05-30), 10-Q (reporting date: 2024-02-29), 10-Q (reporting date: 2023-11-30), 10-K (reporting date: 2023-08-31), 10-Q (reporting date: 2023-06-01), 10-Q (reporting date: 2023-03-02), 10-Q (reporting date: 2022-12-01), 10-K (reporting date: 2022-09-01), 10-Q (reporting date: 2022-06-02), 10-Q (reporting date: 2022-03-03), 10-Q (reporting date: 2021-12-02), 10-K (reporting date: 2021-09-02), 10-Q (reporting date: 2021-06-03), 10-Q (reporting date: 2021-03-04), 10-Q (reporting date: 2020-12-03), 10-K (reporting date: 2020-09-03), 10-Q (reporting date: 2020-05-28), 10-Q (reporting date: 2020-02-27), 10-Q (reporting date: 2019-11-28), 10-K (reporting date: 2019-08-29), 10-Q (reporting date: 2019-05-30), 10-Q (reporting date: 2019-02-28), 10-Q (reporting date: 2018-11-29).


Net income (loss)
The net income generally exhibited a declining trend beginning from a high of 3,296 million USD in late 2018 to negative values starting in late 2022 through early 2024, with the steepest losses in early 2023 reaching -2,312 million USD. Recovery signs appear in mid-2024 with positive income values returning to 1,885 million USD by mid-2025.
Depreciation and Amortization Expense
This expense consistently increased over the observed periods, rising from around 1,335 million USD at the end of 2018 to over 2,090 million USD by mid-2025, indicating ongoing capital asset use and potential asset base growth.
Stock-based Compensation
Stock-based compensation showed a steady upward trend, growing from 61 million USD in late 2018 to 253 million USD by mid-2025, suggesting increasing employee compensation expenses in the form of equity incentives.
Provision to Write-down Inventories and Goodwill Impairment
Provisions for inventory write-downs appeared only in late 2022 and early 2023, with significant amounts reaching 1,430 million USD in one quarter, indicating inventory valuation challenges. A goodwill impairment of 101 million USD was recorded in mid-2023, reflecting an adjustment due to asset value reassessment.
Receivables
Receivables exhibited notable volatility with large positive and negative fluctuations throughout the time frame, indicating inconsistent collections or changes in credit terms. A pronounced dip occurred around early 2023, followed by a moderate recovery.
Inventories
Inventory levels fluctuated, with some quarters showing negative adjustments and others positive. Starting from negative values, inventories peaked positively around late 2020 but declined significantly during 2022 and early 2023, consistent with inventory write-down provisions and possible clearance efforts.
Other Current Assets and Liabilities
Other current assets had sparse data but were negative when reported, potentially reflecting adjustments or reclassifications. Other current liabilities appeared mainly in 2021-2024 with variable but generally negative values, which may signal liability settlements or restructuring activities.
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses fluctuated widely, reflecting changes in payables management and operating cycles. The data show alternating positive and negative swings, with some large negative amounts in 2020 and 2022, possibly due to settlements or operational adjustments.
Change in Operating Assets and Liabilities
This line reflected considerable variability, with some quarters showing large negative impacts on cash flows, especially in 2022 and early 2023, consistent with operating cycle disruptions or inventory/write-down issues.
Adjustments to Reconcile Net Income to Operating Cash Flow
These adjustments remained relatively stable across quarters, mostly ranging between roughly 1,200 million USD and 2,700 million USD, supporting the conversion of accounting income to cash basis.
Net Cash Provided by Operating Activities
Operating cash flows generally trended positively, with peaks above 3,500 million USD in 2021 and continuing strength in late 2024 and early 2025. However, a notable slump occurred in 2022, paralleling net income losses and inventory issues, followed by recovery in subsequent quarters.
Expenditures for Property, Plant, and Equipment (PP&E)
Capital expenditures were substantial throughout and increased over time, peaking at over 4,000 million USD in 2024, indicating sustained investment in fixed assets despite operational headwinds.
Purchases and Proceeds of Available-for-sale Securities
Purchases of securities showed irregular patterns, with some high outflows in early years and a downward adjustment later. The proceeds from maturities and sales had peaks and troughs but consistently contributed to inflows, suggesting active portfolio management.
Proceeds from Government Incentives
Government incentives displayed wide variability, with occasional spikes such as 963 million USD in early 2025, indicating opportunistic capturing of external funding or subsidies.
Net Cash Used for Investing Activities
Consistently negative throughout, reflecting ongoing capital expenditures and securities purchases. The magnitude increased significantly in 2022 and 2024, aligning with higher PP&E spending.
Financing Activities
Financing cash flows were mixed, with periods of debt issuance and repayments fluctuating markedly. Substantial debt issuances occurred sporadically, with repayments large in some quarters, indicating active refinancing or deleveraging. Stock repurchases were significant in early years but reduced or ceased post-2021. Dividend payments were steady but modest relative to other cash activities.
Effect of Currency Exchange Rates
The impact of currency exchange rates on cash held a minor effect with small positive and negative values that did not materially affect overall cash positions.
Net Increase (Decrease) in Cash and Cash Equivalents
The company experienced fluctuating net cash changes, with notable declines in early years and especially in 2022, reflecting operational and investing challenges. Recovery periods in late 2023 through mid-2025 showed positive net increases, consistent with improvements in operating income and cash flow management.